Scientists modelling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions — with implications for cancer treatments in humans.

An international research group has investigated the mechanisms of cell migration and the impact of tissue rigidity on cell positioning and steering. The research sheds light on e.g. cancer cell migration and opens new possibilities for stopping and directing it.

Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific Covid-19 antibodies. This breakthrough could enable faster and more widespread testing in the near future.

Researchers at the UT Southwestern Medical Center have developed a blood test to predict the risk of liver cancer in patients that have the nonalcoholic fatty liver disease. The protein levels in the blood samples of these patients determine if they can develop the deadly disease.

For some years, an active substance from the leaves of an ornamental plant has been regarded as a possible forerunner of a new group of potent drugs. So far, however, it has been very laborious to manufacture it in large quantities. That could now change: Researchers at the University of Bonn have identified a bacterium that produces the substance and can also be easily cultivated in the laboratory.

A study by UCLA has shown that a synthetic IL-9 receptor assists T cell therapy to be carried out to treat cancerous tumors without the need for chemo or radiation.

The Government of India is supporting the indigenous development of high-powered Magnetron technology used mainly for cancer radiation therapy. The innovative technology has the potential to treat even a 2 mm diameter brain tumor with precision radiation with very little side-effects.

An AI tool was assessed by researchers to predict cancer risk in lung nodules. The study was led by the Perelman School of Medicine, University of Pennsylvania and the model seems to work equally well on diagnostic CT and low-dose screening CT.

Scientists from Northwestern Medicine in the USA collaborated with scientists at the University of California, San Francisco and the University of Hong Kong and have identified a drug that has the possibility of becoming the first treatment for aggressive meningiomas that recur.

Researchers at the University of Michigan have developed a noninvasive sound technology which has the potential to partially destroy liver tumors in rats which leads to destroying the remaining tumor with the help of the immune system. This also enables to stop the cancer cells from spreading further. The study could lead to enhanced cancer outcomes in humans.